Integrated nongenomic and genomic actions of thyroid hormone on blood vessels

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 18, Issue 5, 2011, Pages 293-294

  Davis, Paul J ^a  

^a ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

ANGIOGENESIS; EDITORIAL; GENE EXPRESSION; HORMONE ACTION; VASCULAR RESISTANCE;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; THYROID HORMONES;

EID: 80052499465     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32834abeb2     Document Type: Editorial

References (12)

1. Carrillo-Sepulveda MA, Ceravolo GS, Fortes ZB, et al. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc Res 2010; 85:560-570.
2. Hiroi Y, Kim HH,Ying H, etal. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A 2006; 103:14104-14109. (Pubitemid 44452987)
3. Schmidt BM, Martin N, Georgens AC, et al. Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J Clin Endocrinol Metab 2002; 87:1681-1686. (Pubitemid 34615257)
4. Chilian WM, Wangler RD, Peters KG, et al. Thyroxine-induced leftventricular hypertrophy in the rat Anatomical and physiological evidence for angio-genesis. Circ Res 1965; 57:591-598.
5. Liu Y, Wang D, Redetzke RA, et al. Thyroid hormone analog 3, 5-diiodothyr-opropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function. Am J Physiol Circ Physiol 2009; 296:H1551-H1557.
6. Shlenker EH, Hora M, Liu Y, et al. Effects of thyroidectomy, T4, and DITPA replacement on brain blood vessel density in adult rats. Am J Physiol Regul Integr Comp Physiol 2008; 294:R1504-R1509.
7. Bergh JJ, Lin HY, Lansing L, et al. Integrin alphavbeta3 containsa cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005; 146:2864-2871. (Pubitemid 41002793)
8. Davis PJ, Davis FB, Mousa SA, et al. Membrane receptorforthyroid hormone: physiologic and pharmacologic implications. Annu Rev Pharmacol Toxicol 2011; 51:98-115.
9. Glinskii AB, Glinsky GV, Lin HY, et al. Identification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac). Cell Cycle 2009; 8:3554-3562.
10. Moeller LC, Dumitrescu AM, Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol Endocrinol 2005; 19:2955-2963. (Pubitemid 41697714)
11. Davis FB, Mousa SA, O'Connor L, et al. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 2004; 94:1500-1506. (Pubitemid 38780323)
12. El Eter E, Rabee H, Alkayali A, Mousa SA. Role of thyroid hormone analogues in angiogenesis and the development of collaterals in rabbit hind limb ischemia model [abstract]. J Thromb Thrombolysis 2007; 5 (Suppl 1): 375.